Skip to main content

Ki H. Lee, MD

Ki H. Lee, MD

Pediatric Neurologist, Epileptologist

Neuroscience

Ki Hyeong Lee

Overview

Ki Hyeong Lee, MD, MS, is a board-certified neurologist and epileptologist with AdventHealth Medical Group and the Medical Director of AdventHealth for Children’s pediatric epilepsy center in Orlando. A leading provider of diagnostic and surgical techniques for addressing epilepsy and seizures, Dr. Lee completed three prestigious fellowships in clinical neurophysiology, epilepsy research and stroke at the Medical College of Georgia, Mayo Clinic Foundation in Minneapolis and Seoul National University Hospital in Korea, respectively. A noted researcher who regularly presents his work in published articles and international medical forums, he constantly seeks to advance the state of epilepsy patient care through medical breakthroughs and new technologies.

Articles

Intracranial EEG and laser interstitial thermal therapy in MRI-negative insular and/or cingulate epilepsy: case series

JOURNAL OF NEUROSURGERY

2021

Deep Learning Provides Exceptional Accuracy to ECoG-Based Functional Language Mapping for Epilepsy Surgery

FRONTIERS IN NEUROSCIENCE

2020

Altered integrity of corpus callosum in generalized epilepsy in relation to seizure lateralization after corpus callosotomy

NEUROSURGICAL FOCUS

2020

Anakinra usage in febrile infection related epilepsy syndrome: an international cohort

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

2020

Epilepsy Surgery in Children versus Adults

JOURNAL OF KOREAN NEUROSURGICAL SOCIETY

2019

Usefulness of intraoperative insular electrocorticography in modified functional hemispherectomy

BMC NEUROLOGY

2017

Impact of intraoperative 3-T MRI with diffusion tensor imaging on hemispherectomy

JOURNAL OF NEUROSURGERY-PEDIATRICS

2017

The role of executive functioning in quality of life in pediatric intractable epilepsy

EPILEPSY & BEHAVIOR

2016

Identification of Focal Epileptogenic Networks in Generalized Epilepsy Using Brain Functional Connectivity Analysis of Bilateral Intracranial EEG Signals

BRAIN TOPOGRAPHY

2016

Electrocorticography-Based Real-Time Functional Mapping for Pediatric Epilepsy Surgery

JOURNAL OF PEDIATRIC EPILEPSY

2015

Education & Training

Education

Seoul National University College of Medicine

Fellowship

Medical College of Georgia

Specialty

Pediatric Neurology

Board Certifications

American Board of Psychiatry and Neurology

Associated Clinical Trials

NCT05364021

A Phase 1b/2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Dose-Escalation Study to Investigate the Safety, Tolerability, pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of LP352 in Subjects With Developmental and Epileptic Encephalopathies

Icon for trial | LP352-201 A Phase 1b/2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Dose-Escalation Study to Investigate the Safety, Tolerability, pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of LP352 in Subjects With Developmental and E

This study is currently enrolling.

LP352 is being studied to see if it might reduce the number of seizures in patients with DEE. LP352 is thought to work by activating specific sites in the brain that are associated with seizure disorders.

NCT05626634

A Phase 2, multicenter, open-label, long-term safety study of LP352 in subjects with developmental and epileptic encephalopathy who completed Study LP352-201 and are candidates for continuous treatment for up to 52 weeks.

Icon for trial | LP352-202 A Phase 2, multicenter, open-label, long-term safety study of LP352 in subjects with developmental and epileptic encephalopathy who completed Study LP352-201 and are candidates for continuous treatment for up to 52 weeks.

This study is currently enrolling.

You, or you and the individual you care for, are being asked to take part in a research study because you have seizures associated with developmental and epileptic encephalopathy (DEE) and you have completed study LP352-201. L ...